Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Financial Flexibility Index
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥30.67 Million (operating CF CN¥13.19 Million minus capex CN¥17.49 Million) represents 0% of total liabilities (CN¥1.85 Billion). Also explore 600488 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Tianyao Pharmaceuticals Co Ltd Financial Flexibility Index (2000–2024)
Historical Financial Flexibility Index trend for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Check 600488 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year free cash flow to debt coverage for Tianjin Tianyao Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Tianjin Tianyao Pharmaceuticals Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥647.11 Million | CN¥569.37 Million | CN¥1.81 Billion | ▼ -6.9% |
| 2023 | 0.38x | CN¥916.16 Million | CN¥783.01 Million | CN¥2.39 Billion | ▲ +29.8% |
| 2022 | 0.30x | CN¥855.72 Million | CN¥653.52 Million | CN¥2.90 Billion | ▲ +8.6% |
| 2021 | 0.27x | CN¥687.73 Million | CN¥316.89 Million | CN¥2.53 Billion | ▼ -18.8% |
| 2020 | 0.34x | CN¥805.40 Million | CN¥346.88 Million | CN¥2.40 Billion | ▲ +1.7% |
| 2019 | 0.33x | CN¥558.41 Million | CN¥279.37 Million | CN¥1.70 Billion | ▲ +27.3% |
| 2018 | 0.26x | CN¥392.85 Million | CN¥189.27 Million | CN¥1.52 Billion | ▲ +165.5% |
| 2017 | 0.10x | CN¥112.45 Million | CN¥-8.15 Million | CN¥1.15 Billion | ▼ -61.1% |
| 2016 | 0.25x | CN¥128.10 Million | CN¥63.32 Million | CN¥511.21 Million | ▼ -16.2% |
| 2015 | 0.30x | CN¥174.83 Million | CN¥129.50 Million | CN¥584.42 Million | ▼ -23.3% |
| 2014 | 0.39x | CN¥195.54 Million | CN¥178.76 Million | CN¥501.34 Million | ▼ -22.3% |
| 2013 | 0.50x | CN¥394.63 Million | CN¥84.55 Million | CN¥785.64 Million | ▲ +309.5% |
| 2012 | 0.12x | CN¥88.82 Million | CN¥13.23 Million | CN¥724.13 Million | ▼ -36.6% |
| 2011 | 0.19x | CN¥141.24 Million | CN¥78.47 Million | CN¥729.86 Million | ▼ -5.8% |
| 2010 | 0.21x | CN¥264.58 Million | CN¥116.82 Million | CN¥1.29 Billion | ▼ -65.6% |
| 2009 | 0.60x | CN¥637.45 Million | CN¥435.13 Million | CN¥1.07 Billion | ▲ +10.5% |
| 2008 | 0.54x | CN¥576.94 Million | CN¥219.31 Million | CN¥1.07 Billion | ▲ +19.3% |
| 2007 | 0.45x | CN¥387.07 Million | CN¥162.33 Million | CN¥854.65 Million | ▲ +401.9% |
| 2006 | 0.09x | CN¥121.63 Million | CN¥50.72 Million | CN¥1.35 Billion | ▲ +78.0% |
| 2005 | 0.05x | CN¥47.32 Million | CN¥-108.87 Million | CN¥933.43 Million | ▼ -88.7% |
| 2004 | 0.45x | CN¥243.77 Million | CN¥110.30 Million | CN¥541.10 Million | ▲ +37.0% |
| 2003 | 0.33x | CN¥220.01 Million | CN¥45.77 Million | CN¥669.25 Million | ▼ -3.6% |
| 2002 | 0.34x | CN¥216.48 Million | CN¥45.28 Million | CN¥634.50 Million | ▲ +18.8% |
| 2001 | 0.29x | CN¥120.44 Million | CN¥71.87 Million | CN¥419.39 Million | ▲ +8.1% |
| 2000 | 0.27x | CN¥77.35 Million | CN¥41.06 Million | CN¥291.03 Million | — |